TBOEP in the bedroom

At a glance

What it is

TBOEP is a slightly viscous liquid at room temperature with relatively low volatility, which is part of why it persists in indoor environments and migrates slowly from the host material over time. It functions both as a flame retardant in polyurethane foam and as a plasticizer in PVC and synthetic rubber. It was historically a common additive in floor polish, which is why TBOEP and its metabolite BBOEP often dominate the OPE biomarker profile in residential studies of households with vinyl flooring or routine floor-wax use.

Like the other organophosphate ester flame retardants, TBOEP is not chemically bonded to the polymer matrix of the materials it is added to. It migrates out through abrasion, partition into adjacent materials, and direct transfer to dust and skin during contact. The 2025 Diamond and colleagues study of children's sleep microenvironments was the first to directly characterize OPE emission from mattresses to the immediate sleep zone in a controlled residential setting, and TBOEP topped the list of OPEs measured. Peer-reviewed — Diamond et al. 2025, PMC12080337

The CNN summary of the 2025 study and the companion work from the Diamond group at the University of Toronto stated plainly: "heat and weight on a mattress can amplify the emission of harmful chemicals." That description, while informal, accurately captures the quantitative finding that body warmth and pressure on foam measurably increase the rate of SVOC release.

How it gets to the bedroom

From the mattress foam itself

The 2025 Diamond study placed semi-volatile organic compound samplers in the sleep microenvironments of 25 children aged 6 months to 4 years. Of the 30 SVOCs measured, TBOEP had the highest median concentration among OPEs, with concentrations near the bed higher than in the bedroom generally. Peer-reviewed — Diamond et al. 2025, PMC12080337 The mattress is a major source for this compound class in the immediate sleep zone, and TBOEP specifically appears to dominate the OPE emission profile from current-manufacture foam.

From vinyl flooring and floor polish

TBOEP has been a common additive in floor polish and vinyl flooring formulations for decades. Households with vinyl flooring or routine floor-wax application typically show elevated BBOEP urinary metabolite levels relative to households without these sources. Peer-reviewed The dust contribution from flooring to bedrooms occurs through air circulation and through dust tracking on feet and bedding.

From house dust

TBOEP is detectable in essentially all U.S. and Canadian house dust samples tested in recent surveys. Bedroom dust samples often have higher TBOEP concentrations than other rooms due to the combined contribution of mattresses, electronics, and the lower air circulation that allows dust to accumulate on bedding surfaces.

From dermal contact with the foam

The Diamond study explicitly identified that body heat and weight on foam mattresses enhance SVOC emission rates. The mechanism is consistent with the broader literature on temperature-enhanced percutaneous absorption: warm skin in occluded contact with a flame-retarded foam mattress for six to eight hours per night creates near-optimal conditions for the foam to release its additives and for the skin to absorb them.

What the research says

Thyroid hormone transport disruption

Hill and colleagues 2018 demonstrated in vitro that TBOEP enhances thyroxine binding to human transthyretin, with significant increases at TBOEP concentrations as low as 64 nanomolar and up to 184 percent of control values at 5000 nanomolar. Peer-reviewed — Hill 2018, Toxicology Letters Transthyretin is the primary carrier of thyroid hormone in blood; perturbing T4-TTR binding disrupts thyroid hormone transport and bioavailability. This is one of the cleanest mechanistic findings for any OPE in the thyroid axis.

Developmental neurotoxicity (general)

The 2021 Patisaul and colleagues review in Environmental Health Perspectives synthesized the evidence that OPEs, including TBOEP, exert non-cholinergic developmental neurotoxicity through perturbation of glutamate and gamma-aminobutyric acid neurotransmission and through endocrine disruption. Peer-reviewed — Patisaul 2021, Environmental Health Perspectives The 2024 Shahin review of 48 OPE health-outcome papers documented developmental neurotoxicity findings spanning cognition, motor function, and behavioral problems for the OPE class as a whole. Peer-reviewed — Shahin 2024, Environmental Research

Behavioral and cognitive outcomes

Several large prospective cohorts have associated BBOEP (the urinary metabolite of TBOEP) with behavioral outcomes in children. The Oh and colleagues 2025 analysis of 2,948 mother-child dyads in 12 ECHO cohorts found that low BBOEP exposure was associated with higher T-scores on the Child Behavior Checklist for internalizing, externalizing, and total problems composite scales. Peer-reviewed — Oh 2025, Environment International Hernandez-Castro and colleagues 2023 in the MADRES pregnancy cohort found that detectable maternal BBOEP was associated with higher externalizing T-scores in three-year-old children. Peer-reviewed — Hernandez-Castro 2023, Environmental Health

Hepatic and hemolytic effects (rodent)

Older OECD toxicology data on TBOEP indicate liver enlargement and hemolytic effects in rodents at moderate-to-high oral doses. The contemporary biomonitoring data suggest typical human exposures are several orders of magnitude below those rodent doses, but the cumulative load with co-occurring OPEs and the longer-than-rodent human exposure duration introduce uncertainty.

Open questions

Specific TBOEP emission rates from current-manufacture U.S. mattresses are not yet well characterized outside the Diamond 2025 study cohort. The mechanism of TBOEP-induced developmental neurotoxicity is less well-defined than for the chlorinated tris OPEs (TDCPP, TCPP). Activated carbon chamber-testing of TBOEP-specific capture at realistic sleep environment temperatures and humidities has not been independently published.

What helps reduce exposure

• Tier 1 — Most effective: Ventilate the bedroom during the day, especially when mattresses are warm. Avoid routine wet-mopping or polishing of vinyl flooring with products that contain TBOEP. Replace flooring with non-vinyl alternatives during renovations. Remove old foam-cored furniture from sleeping areas where possible.
• Tier 2 — Worth considering: Use a mattress cover that limits direct skin-foam contact and reduces dust deposition on the foam. The Embr capture layer is designed to adsorb alkyl organophosphate esters including TBOEP at the foam-bedding interface; this addresses one component of the cumulative load but does not replace ventilation or source reduction.
• Tier 3 — Larger interventions: Replace older foam mattresses with current-manufacture flame-retardant-free alternatives that pass smolder testing without chemical flame retardants. Specify hard flooring (sealed wood, tile, linoleum without TBOEP) during renovation rather than vinyl.

What does NOT help

• HEPA filtration alone. TBOEP is semi-volatile and partitions strongly to surfaces. HEPA captures dust-bound TBOEP but does not stop ongoing emission from the foam.
• Surface cleaning the mattress. TBOEP migrates from within the foam over time; surface cleaning addresses neither the source nor the ongoing emission.
• "Organic cotton" labeling without OPE-free specification. Cotton fabric content is irrelevant to OPE content in the foam core. A cotton-covered mattress with TBOEP-containing foam is still a TBOEP source.

Open research questions

• TBOEP-specific emission rates from current-manufacture U.S. mattresses across product categories — budget, mid-market, premium — are not yet quantified outside the Diamond 2025 sample of children's mattresses.
• The relative contribution of mattress, flooring, electronics, and dust to total household TBOEP exposure has not been apportioned in residential settings, leaving source-reduction guidance under-supported.
• The interaction between TBOEP and the co-occurring OPEs (TDCPP, TCPP, TPHP) on cumulative urinary metabolite load and on health outcomes is an active area where mixture-model studies are beginning to publish but remain under-powered.
• Activated carbon capture efficiency for TBOEP specifically, under realistic sleep environment conditions (35°C body-warm foam, 50-70 percent relative humidity, six-hour contact time), warrants independent chamber characterization. This is a gap the Embr foundation arm research direction could address.

Citations

1. Diamond M et al. 2025. Young Children's Exposure to Chemicals of Concern in Their Sleeping Microenvironment. ACS EST.
2. Hill KL et al. 2018. OP triesters enhance T4 binding to transthyretin. Toxicology Letters.
3. Patisaul HB et al. 2021. Beyond Cholinesterase Inhibition: Developmental Neurotoxicity of OPE Flame Retardants. Environmental Health Perspectives.
4. Shahin S et al. 2024. OPEs and maternal-child health, 48-paper review. Environmental Research.
5. Oh J et al. 2025. Prenatal OPE flame retardants and child behavioral outcomes in ECHO. Environment International.
6. Hernandez-Castro I et al. 2023. Prenatal OPE metabolite mixtures and child neurobehavior in MADRES. Environmental Health.
7. CNN 2025. Brain-harming chemicals released from mattresses while children sleep. https://www.cnn.com/2025/04/15/health/child-mattress-bedding-toxins-wellness
8. Consumer Reports 2025. Mattresses Can Be Source of Harmful Chemicals in Kids' Rooms. https://www.consumerreports.org/babies-kids/childrens-health/mattresses-can-be-source-of-harmful-chemicals-in-kids-rooms-a5263703680/

Related compounds

• TDCPP — chlorinated tris OPE, one of the other major OPE classes in current foam
• TCPP — tris(1-chloro-2-propyl) phosphate, related chlorinated alkyl OPE
• TPHP — triphenyl phosphate, aryl OPE found in foam and electronics
• PBDEs — the legacy PBDE family that OPEs replaced after 2005

Embr's capture layer is designed to adsorb organophosphate ester flame retardants including TBOEP at the foam-bedding interface. The system reduces a portion of the exposure pathway. It is not a treatment for any condition and does not substitute for source reduction, ventilation, or regulatory action on flame retardant chemistry.

Last reviewed May 2026. If you find an error, contact us.